En español
NIDA

Methadone Treatment

Former NIDA International fellows and their international partners have published findings from research funded through RFA-DA-10-008, International Research Collaborations on HIV/AIDS and Drug Use. The funding opportunity was issued to stimulate collaborative research among foreign investigators from the same geographic regions to address regional issues on the intersection of HIV/AIDS and drug use in international settings. The articles include:

Perrine Roux, Pharm.D., Ph.D., French National Institute of Health and Medical Research (Inserm), has been selected as a NIDA INVEST Drug Abuse Research Fellow. She will work with Sandra D. Comer, Ph.D., Columbia University, to better define the concept of nonadherence to opioid maintenance treatment with buprenorphine/naloxone and to validate a tool to measure nonadherence using a self-administered questionnaire.

The governments of Tanzania and the United States have announced that the first medication- assisted therapy (MAT) program for drug users in sub-Saharan Africa will begin shortly at two sites in Dar es Salaam and one in Zanzibar. Recognizing that high-risk practices related to drug use contribute to HIV transmission, the Tanzania Drug Control Commission (DCC) has promoted and adopted novel and evidence-based interventions to facilitate improved access to services that prevent HIV among drug users.